Clinical Trial

FIBERGRAFT Aeridyan Posterolateral Fusion Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be conducted at up to 10 clinical sites within the United States.
Protocol Amendment History 3 changes
minor Completion pushed: 2029-05-31 -> 2029-07-31 2026-07-07
notable Primary completion pushed: 2026-03-01 -> 2029-05-31 2026-04-14
minor Completion pushed: 2028-12-29 -> 2029-05-31 2026-04-14
Trial Details
NCT Number NCT07059065
Lead Sponsor DePuy Synthes Products, Inc.
Conditions Degenerative Spine Disease
Enrollment 316 participants
Start Date 2025-08-15
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-06